新冠疫情后期细胞病理学实践影响的国际多中心研究
该研究通过第二次全球调查收集2020年疫情封锁后12周的细胞病理学数据,比较封锁后与2019年同期的标本量和恶性诊断率。结果显示标本总量减少26.5%,但恶性诊断率从4.01%升至5.26%(P < .001),恶性及可疑恶性合计率从4.98%升至6.58%(P < .001)。
要点
- 封锁后细胞病理标本量较2019年同期减少26.5%
- 恶性诊断率显著升高(5.26% vs 4.01%,P < .001)
- 恶性及可疑恶性合计率亦显著升高(6.58% vs 4.98%,P < .001)
核心结论
- 封锁后期间细胞病理标本量持续减少,但恶性诊断率相对升高。
- 封锁后后期细胞病理工作量相对增加,提示缓慢恢复常态。
研究设计与样本
- 共29名受访者来自17个国家参与调查。
- 比较封锁后期间与2019年同期的标本量及恶性诊断率差异。
主要发现
- 封锁后期间细胞病理标本总数为236,352例,2019年同期为321,466例,相对减少26.5%。
- 总体恶性诊断率显著升高:12,442例(5.26%) vs 12,882例(4.01%),P < .001。
- 恶性及可疑恶性合计率显著升高:15,759例(6.58%) vs 16,011例(4.98%),P < .001。
临床怎么用
- 疫情后细胞病理标本量减少但恶性比例升高,提示需关注筛查延迟导致的病变浓缩效应。
- 细胞病理科室应关注封锁后后期工作量回升趋势,合理安排资源。
局限性
- 调查基于自愿参与的29名受访者,样本量有限且可能不具全球代表性。
- 数据为回顾性收集,各国家封锁后时间段不完全一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In a previous worldwide survey, the authors showed a drastic reduction in the number of cytological specimens processed during the coronavirus disease 2019 "lockdown" period along with an increase in malignancy rates. To assess the continued impact of the pandemic on cytological practices around the world, they undertook a second follow-up worldwide survey collecting data from the post-lockdown period (2020). METHODS: Participants were asked to provide data regarding their cytopathology activity during the first 12 weeks of their respective national post-lockdown period (2020), which ranged from April 4 to October 31. Differences between the post-lockdown period and the corresponding 2019 period were evaluated, and the authors specifically focused on rates of malignant diagnoses. RESULTS: A total of 29 respondents from 17 countries worldwide joined the survey. Overall, a lower number of cytological specimens (n = 236,352) were processed in comparison with the same period in 2019 (n = 321,466) for a relative reduction of 26.5%. The overall malignancy rate showed a statistically significant increase (12,442 [5.26%] vs 12,882 [4.01%]; P < .001) during the same time period. Similar results were obtained if both malignancy and suspicious for malignancy rates were considered together (15,759 [6.58%] vs 16,011 [4.98%]; P < .001). CONCLUSIONS: The data showed a persistent reduction in the cytological specimen volume during the post-lockdown period (2020). However, the relative increase in the cytological workload in the late part of the post-lockdown is a promising finding of a slow return to normality.
引用
- Vigliar E, Pisapia P, Dello Iacovo F, et al. COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study. Cancer Cytopathol. 2022. PMID: 35006650. doi:10.1002/cncy.22547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。